B cell activation and the establishment of Epstein-Barr virus latency
- PMID: 2848918
- PMCID: PMC2189139
- DOI: 10.1084/jem.168.6.2059
B cell activation and the establishment of Epstein-Barr virus latency
Abstract
Linear EBV genomes undergo a transition to the circular form characteristic of latency by 16-20 h post-infection. This transition requires that the infected cells be activated to the G1 stage of the cell cycle. Cellular proliferation and expression of the activation marker CD23 were not required. Nevertheless, 36 h post-infection, only cells expressing CD23 contained covalently closed, circular episomes (CCC), at an average of one copy per cell. Since the presence of CD23 at this time is predictive that a cell will immortalize, we suggest that the presence of CCC is required for CD23 expression and subsequent immortalization. The one CCC present in each CD23+ cell did not undergo amplification until well after the cells had acquired all of the characteristic phenotypic markers of immortalization. Therefore, while amplification is not necessary for proliferation and immortalization, circularization of a single genome is crucial to the establishment and maintenance of latency by EBV.
Similar articles
-
Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.Leukemia. 1995 May;9(5):747-53. Leukemia. 1995. PMID: 7539512
-
Activation and immortalization of leukaemic B cells by Epstein-Barr virus.Int J Cancer. 1989 Nov 15;44(5):846-53. doi: 10.1002/ijc.2910440517. Int J Cancer. 1989. PMID: 2555307
-
Immortalization of Epstein-Barr virus-infected CD23-negative B lymphocytes by the addition of B cell growth factor.J Gen Virol. 1990 Mar;71 ( Pt 3):665-71. doi: 10.1099/0022-1317-71-3-665. J Gen Virol. 1990. PMID: 2155999
-
Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Eur J Cell Biol. 2012. PMID: 21450364 Review.
-
Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.Leuk Lymphoma. 1996 May;21(5-6):379-90. doi: 10.3109/10428199609093435. Leuk Lymphoma. 1996. PMID: 9172802 Review.
Cited by
-
Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.Cancer Sci. 2010 Apr;101(4):876-81. doi: 10.1111/j.1349-7006.2009.01474.x. Epub 2009 Dec 16. Cancer Sci. 2010. PMID: 20132216 Free PMC article.
-
Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53.EMBO J. 1995 Apr 3;14(7):1382-91. doi: 10.1002/j.1460-2075.1995.tb07124.x. EMBO J. 1995. PMID: 7729416 Free PMC article.
-
Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48).Mol Cell Biol. 1991 Mar;11(3):1614-23. doi: 10.1128/mcb.11.3.1614-1623.1991. Mol Cell Biol. 1991. PMID: 1847502 Free PMC article.
-
Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus.Virol J. 2011 Feb 25;8:84. doi: 10.1186/1743-422X-8-84. Virol J. 2011. PMID: 21352549 Free PMC article.
-
Early establishment of gamma-herpesvirus latency: implications for immune control.J Immunol. 2005 Apr 15;174(8):4972-8. doi: 10.4049/jimmunol.174.8.4972. J Immunol. 2005. PMID: 15814726 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources